Investing in the future: Lessons learnt from communicating the results of HSV/ HIV intervention trials in South Africa

Health Research Policy and Systems

Volumn 9, Issue SUPPL. 1, 2011, Pages

  Delany Moretlwe, Sinead ^a   Stadler, Jonathan ^a   Mayaud, Philippe ^b   Rees, Helen ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ARTICLE; COMMUNICATION PROTOCOL; HEALTH CARE POLICY; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL CHANGE; SOUTH AFRICA; TREATMENT DURATION;

EID: 79958821223     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-9-S1-S8     Document Type: Article

References (28)

1. Report on the global HIV/AIDS epidemic 2008. , http://data.unaids.org/pub/GlobalReport/2008/jc1510_2008_global_report_pp29_62_en.pdf
2. United Nations Millennium Declaration (Resolution A/55/2). , http://www.un.org/millennium/declaration/ares552e.pdf
3. Fassin D, Schneider H. The politics of AIDS in South Africa: beyond the controversies. BMJ 2003, 326(7387):495-497. 10.1136/bmj.326.7387.495, 1125376, 12609950.
4. Niehaus I, Jonsson G. Dr. Wouter Basson, Americans, and wild beasts: men's conspiracy theories of HIV/AIDS in the South African Lowveld. Med Anthropol 2005, 24(2):179-208. 10.1080/01459740590933911, 16019570.
5. Stadler J. Rumor, gossip and blame: implications for HIV/AIDS prevention in the South African lowveld. AIDS Educ Prev 2003, 15(4):357-368. 10.1521/aeap.15.5.357.23823, 14516020.
6. Butler A. South Africa's HIV/AIDS policy, 1994-2004: How can it be explained?. Afr Aff (Lond) 2005, 104(417):591-614.
7. Hlongwa W. Medical research trial guinea pigs contract HIV. City Press 2007, Johannesburg: News24.
8. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20(1):73-83. 10.1097/01.aids.0000198081.09337.a7, 16327322.
9. Celum CL, Robinson NJ, Cohen MS. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis 2005, 191(Suppl 1):S107-114.
10. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005, 2(11):e298. 10.1371/journal.pmed.0020298, 1262556, 16231970.
11. Ramjee G, Govinden R, Morar NS, Mbewu A. South Africa's experience of the closure of the cellulose sulphate microbicide trial. PLoS Med 2007, 4(7):e235. 10.1371/journal.pmed.0040235, 1950203, 17685664.
12. Staff AIDS Shock!. Daily Sun 2007, Johannesburg: Media24, Staff.
13. Nagot N, Ouedraogo A, Foulongne V, Konate I, Weiss HA, Vergne L, Defer MC, Djagbare D, Sanon A, Andonaba JB, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007, 356(8):790-799. 10.1056/NEJMoa062607, 17314338.
14. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, Mugeye K, Tanton C, Ross D, Everett D, Clayton T, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008, 358(15):1560-1571. 10.1056/NEJMoa0800260, 2643126, 18337596.
15. Saethre EJ, Stadler J. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy. Anthropology & Medicine 2010, 17(1):99-111. 10.1080/13648470903569396, 21519673.
16. Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371(9630):2109-2119. 10.1016/S0140-6736(08)60920-4, 2650104, 18572080.
17. Delany S, Mlaba N, Clayton T, Akpomiemie G, Capovilla A, Legoff J, Belec L, Stevens W, Rees H, Mayaud P. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS 2009, 23(4):461-469. 10.1097/QAD.0b013e32831db217, 2948532, 19155993.
18. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010, 362(5):427-39. 10.1056/NEJMoa0904849, 2838503, 20089951.
19. Paz-Bailey G, Sternberg M, Puren AJ, Markowitz LE, Ballard R, Delany S, Hawkes S, Nwanyanwu O, Ryan C, Lewis DA. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. J Infect Dis 2009, 200(7):1039-1049. 10.1086/605647, 19715417.
20. Innvaer S, Vist G, Trommald M, Oxman A. Health policy-makers' perceptions of their use of evidence: a systematic review. J Health Serv Res Policy 2002, 7:239-244. 10.1258/135581902320432778, 12425783.
21. Dorsey ER, Beck CA, Adams M, Chadwick G, de Blieck EA, McCallum C, Briner L, Deuel L, Clarke A, Stewart R, et al. Communicating Clinical Trial Results to Research Participants. Arch Neurol 2008, 65(12):1590-1595. 10.1001/archneurol.2008.503, 19064746.
22. Dixon-Woods M, Jackson C, Windridge KC, Kenyon S. Receiving a summary of the results of a trial: qualitative study of participants' views. BMJ 2006, 332(7535):206-210. 10.1136/bmj.38675.677963.3A, 1352050, 16401631.
23. Dinnett EM, Mungall MM, Gordon C, Ronald ES, Gaw A. Offering results to research participants. BMJ 2006, 332(7540):549-550. 1388167, 16513720.
24. MacNeil SD, Fernandez CV. Offering results to research participants is ethically right but not yet fully explored. BMJ 2006, 332:188-189. 10.1136/bmj.332.7535.188, 1352038, 16439373.
25. Shalowitz DI, Miller FG. Communicating the results of clinical research to participants: attitudes, practices, and future directions. PLoS Med 2008, 5(5):e91. 10.1371/journal.pmed.0050091, 2375946, 18479180.
26. Department of H. Guidelines for Good Practice in the Conduct of Clinical Trials with Human Participants in South Africa. 2006, 37. Pretoria:Department of Health.
27. UNAIDS Good participatory practice guidelines for biomedical HIV prevention trials. 2007, 1-66. Geneva, UNAIDS/07.30E/JC1364E(English original November 2007)edn, UNAIDS.
28. Miller L, Bass E, Warren M, Grant D, Costelloe-Kuhn A, Feuer C, Fisher K. Good participatory practice guidelines begin to take root. Retrovirology 2009, 6(Suppl 3):P225.